| Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More | Sarah de Crescenzo | 08/21/20 | National |
| Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies | Sarah de Crescenzo | 06/26/20 | San Diego |
| Fate Inks $100M Deal With Janssen for Stem Cell-Derived Cancer Therapies | Sarah de Crescenzo | 04/03/20 | San Diego |
| Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More | Sarah de Crescenzo | 04/03/20 | National |
| ViaCyte, Fate & More: Xconomy Awards San Diego Big Idea Finalists | Sarah de Crescenzo | 05/16/19 | San Diego |
| Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More | Alex Lash | 09/09/16 | National |
| Fate Therapeutics Lands $10,290,000 New Funding Round | VentureDeal | 08/24/16 | San Diego |
| West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More | Bruce V. Bigelow | 01/29/16 | San Diego |
| At Cellular Dynamics, The Beat Goes On Under Fujifilm Ownership | Jeff Buchanan | 11/25/15 | Wisconsin |
| West Coast Biotech Roundup: Audentes, Fate, Zosano & More | Bruce V. Bigelow | 10/15/15 | National |
| West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More | Alex Lash | 05/22/15 | San Diego |
| Fate Therapeutics, Riding High on Juno Deal, Raising More Cash | Bruce V. Bigelow | 05/19/15 | San Diego |
| Fate Therapeutics Receives $8,000,000 New Financing Round | VentureDeal | 05/18/15 | San Diego |
| West Coast Biotech Roundup: Adaptive, Gilead, Juno, aTyr & More | Alex Lash | 05/08/15 | Boston |
| Insulin Pump Maker Tandem Diabetes Plans to Raise $100M Through IPO | Bruce V. Bigelow | 10/08/13 | San Diego |
| San Diego Life Sciences Roundup: Fate, Ligand, BioNano, and More | Bruce V. Bigelow | 10/04/13 | San Diego |
| Fate Therapeutics Receives $40,200,000 New Financing Round | VentureDeal | 10/01/13 | San Diego |
| San Diego Life Sciences Roundup: Evoke Pharma, Isis, Otonomy, & More | Bruce V. Bigelow | 09/06/13 | San Diego |
| San Diego Life Sciences Roundup: Vical, Sequenom, Sophiris, and More | Bruce V. Bigelow | 08/23/13 | San Diego |
| San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More | Bruce V. Bigelow | 08/15/13 | San Diego |
| Fate Therapeutics Joins Biotech IPO Conga Line, Reaching for $69M | Luke Timmerman | 08/14/13 | San Diego |
| Fate Therapeutics Receives $20,000,000 New Funding | VentureDeal | 08/13/13 | San Diego |
| San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More | Bruce V. Bigelow | 10/19/12 | San Diego |
| MGH Medicine Head Ausiello to Join Oct. 4 Xconomy Life Science Forum | Robert Buderi | 09/24/12 | Boston |
| San Diego Life Sciences Roundup: Regulus IPO, Fate Funding, & More | Bruce V. Bigelow | 08/23/12 | San Diego |
| Fate Therapeutics Secures $9,244,679 New Round | VentureDeal | 08/22/12 | San Diego |
| Late Add: John Mendlein Joins “Reinventing Biotech” Lineup April 3 | Luke Timmerman | 03/29/12 | Seattle |
| San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More | Bruce V. Bigelow | 12/16/11 | San Diego |
| Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO | Luke Timmerman | 12/14/11 | San Diego |
| Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News | Luke Timmerman | 10/13/11 | Seattle |
